Clinical Trial Update: Effect of Schisandra Chinensis Extract on Musculoskeletal Biomakers in Relatively Sarcopenic Adults: a RCT [NA]

View source ↗

Summary

Completion of a randomized controlled trial evaluating Schisandra chinensis extract for improving musculoskeletal biomarkers in relatively sarcopenic adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcopenia

Drugs mentioned

• Schisandra chinensis extract (Schisandra chinensis extract)

Snippet

Sponsor: Pusan National University Yangsan Hospital | Conditions: Muscular Sarcoidosis | NA | Status: COMPLETED